Role of Alprazolam in Management of Post Endodontic Pain After Single Visit Root Canal Treatment. To Compare Mean Pain Score Between Two Group of Participants Undergoing Post Operative Pain Management After Single Visit Root Canal Treatment: NSAIDs Alone and a Combination of NSAIDs and Alprazolam.

ConditionPain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorArmed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi

About this trial

To compare mean pain score between two group of participants undergoing post operative pain management after single visit root canal treatment: one group receiving NSAIDs alone and the other receiving a combination of NSAIDs and an anxiolytic medication i.e alprazolam.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients aged between 18-60 years

healthy patients with ASA classification I and II

Teeth with symptomatic irreversible pulpitis

Disqualifiers

patient suffering from systemic disease that requires antibiotics

pregnant or lactating mothers

teeth with periapical radiolucency

teeth with severe periodontitis

Trial design

Design model

Parallel

Treatments tested in this trial

  • Brufen and alprazolam

    Combination product

    second group in the study will be prescribed 400mg ibuprofen and 0.5mg alp tablet for management of post endodontic pain after root canal treatment

  • Brufen

    Drug

    one group in the study will be prescribed 400mg ibuprofen for management of post endodontic pain after root canal treatment

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: brufenActive comparator 1 intervention
Group B: alprazolamActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

pain levels

patients will be randomly assigned to one of two groups: * Group 1: Ibuprofen 400 mg (Abbott Brufen) * Group 2: Ibuprofen 400 mg (Abbott Brufen) + Alprazolam 0.5 mg (Hilton Pharma Alp) Pain Assessment Participants will be provided with a pain diary containing a 10 cm Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst possible pain). They will record their pain intensity at 6, 12, and 24 hours after treatment. Pain diaries will be collected during the one-week follow-up visit. Data will be used to compare mean VAS scores between groups to evaluate the efficacy of the two analgesic regimens.

Time frame
6 hours 12 hours 24 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.